MoneyWorks4Me

Gujarat Themis Biosyn gets nod to raise Rs 585 crore via NCDs

11 Sep 2026 Evaluate

Gujarat Themis Biosyn has received approval for the issuance of Non-Convertible Debentures (NCDs) aggregating upto Rs 585 crore on private placement basis. The Board of Directors of the Company at its meeting held on September 10, 2026, has inter-alia considered and approved the same. 

Gujarat Themis Biosyn is a biotech and synthetic product manufacturing company.


Peers
Company Name CMP
Sun Pharma. Inds. 1845.00
Dr. Reddys Labs. 1175.20
Cipla 1359.00
Lupin 2093.05
Zydus Lifesciences 1120.00
View more..